Insider Distribution Broadens Across Healthcare and Tech as Buying Narrows to Small-Cap Value
Merck, Twilio, Corcept and A10 Networks executives cut holdings totalling more than $9 million, while insider accumulation appears confined to Celanese and Biote — a divergence historically consistent with late-cycle valuation stress.
A cluster of Form 4 filings shows concentrated executive selling: Merck EVP DeLuca disposed of $5.9 million, Corcept's chief development officer sold $1.8 million, Twilio director Erika Rottenberg sold $881,000, and A10 Networks' general counsel sold $392,435. Avalo Therapeutics saw both its CMO and CSO reduce stakes. Insider buying was materially smaller and concentrated in value names, with Celanese SVP Murray purchasing $98,004 and Biote executive chairman Marc Beer acquiring over $202,000. Cathie Wood's ARK also trimmed $11.6 million from a surging tech position.